Siga Technologies (United States)
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Siga Technologies (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
73%
Total
Publications
117
Total Open
Publications
85
Total
Citations
5.4K
Open Access
Percentage
73%
Total
Publications
117
Total Open
Publications
85
Total
Citations
5.4K
Breakdown
Publisher Open
5%
Both
35%
Other Platform Open
33%
Closed
27%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
11
Hybrid 13%
6
No Guarantees 64%
30
Other Platform Open
Domain 96%
76
Institution 8%
6
Public 6%
5
Preprint 3%
2
Other Internet 3%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 76 |
Europe PMC | Domain | 64 |
Semantic Scholar | Public | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE UNDEFINED | Other Internet | 2 |
bioRxiv | Preprint | 2 |
usu.edu OAI-PMH Repository | Institution | 1 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
umt.edu OAI-PMH Repository | Institution | 1 |